Daniel R. Gaya

Glasgow, SCT, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 68 publications

Mechanistic insights into fecal microbiota transplantation for the treatment of ulcerative colitis: analysis of the STOP-Colitis trial.

Mechanistic insights into fecal microbiota transplantation for the treatment of ulcerative colitis: analysis of the STOP-Colitis trial.

Journal: Journal of Crohn's & colitis

Published: January 26, 2026

Associations between demographic, clinical and dietary factors and flares in inflammatory bowel disease: the PRognostic effect of Environmental factors in Crohn's and Colitis (PREdiCCt) prospective cohort study.

Associations between demographic, clinical and dietary factors and flares in inflammatory bowel disease: the PRognostic effect of Environmental factors in Crohn's and Colitis (PREdiCCt) prospective cohort study.

Journal: Gut

Published: December 12, 2025

Patient Acceptability of Partial Enteral Nutrition as a Concomitant Therapy to Adalimumab in Adults with Active Crohn's Disease: BIOPIC Trial.

Patient Acceptability of Partial Enteral Nutrition as a Concomitant Therapy to Adalimumab in Adults with Active Crohn's Disease: BIOPIC Trial.

Journal: Annals of nutrition & metabolism

Published: July 08, 2025

Inter- and Intraobserver Variability in Bowel Preparation Scoring for Colon Capsule Endoscopy: Impact of AI-Assisted Assessment Feasibility Study.

Inter- and Intraobserver Variability in Bowel Preparation Scoring for Colon Capsule Endoscopy: Impact of AI-Assisted Assessment Feasibility Study.

Journal: Cancers

Published: July 01, 2025

The evolution of ScotRIGHT: The first pan-Scotland physician trainee research network.

The evolution of ScotRIGHT: The first pan-Scotland physician trainee research network.

Journal: The journal of the Royal College of Physicians of Edinburgh

Published: August 31, 2023

Development and Validation of the Glasgow Exclusive Enteral Nutrition Index of Compliance.

Development and Validation of the Glasgow Exclusive Enteral Nutrition Index of Compliance.

Journal: Journal of Crohn's & colitis

Published: April 02, 2023

Safety, Effectiveness, and Treatment Persistence of Subcutaneous Vedolizumab in IBD: A Multicenter Study From the United Kingdom.

Safety, Effectiveness, and Treatment Persistence of Subcutaneous Vedolizumab in IBD: A Multicenter Study From the United Kingdom.

Journal: Inflammatory bowel diseases

Published: December 15, 2022

Clinical trial: Clinical and endoscopic outcomes with ustekinumab in patients with Crohn's disease: Results from the long-term extension period of STARDUST.

Clinical trial: Clinical and endoscopic outcomes with ustekinumab in patients with Crohn's disease: Results from the long-term extension period of STARDUST.

Journal: Alimentary pharmacology & therapeutics

Published: December 05, 2022

Ustekinumab improves health-related quality of life in patients with moderate-to-severe Crohn's disease: Results up to Week 104 of the STARDUST trial.

Ustekinumab improves health-related quality of life in patients with moderate-to-severe Crohn's disease: Results up to Week 104 of the STARDUST trial.

Journal: United European gastroenterology journal

Published: November 18, 2022

Letter: non-selective beta-blockers in cirrhosis-effect beyond portal hypertension. Authors' reply.

Letter: non-selective beta-blockers in cirrhosis-effect beyond portal hypertension. Authors' reply.

Journal: Alimentary pharmacology & therapeutics

Published: June 10, 2022

Implications for sequencing of biologic therapy and choice of second anti-TNF in patients with inflammatory bowel disease: results from the IMmunogenicity to Second Anti-TNF therapy (IMSAT) therapeutic drug monitoring study.

Implications for sequencing of biologic therapy and choice of second anti-TNF in patients with inflammatory bowel disease: results from the IMmunogenicity to Second Anti-TNF therapy (IMSAT) therapeutic drug monitoring study.

Journal: Alimentary pharmacology & therapeutics

Published: June 05, 2022

The Effects of Commonly Consumed Dietary Fibres on the Gut Microbiome and Its Fibre Fermentative Capacity in Adults with Inflammatory Bowel Disease in Remission.

The Effects of Commonly Consumed Dietary Fibres on the Gut Microbiome and Its Fibre Fermentative Capacity in Adults with Inflammatory Bowel Disease in Remission.

Journal: Nutrients

Published: January 19, 2022

Showing 1-12 of 68

Last Updated: 09/26/2026